METHODS AND COMPOSITIONS FOR TREATMENT OF COVID-19

    公开(公告)号:US20230022162A1

    公开(公告)日:2023-01-26

    申请号:US17936379

    申请日:2022-09-28

    发明人: Rafi Israel

    摘要: A method of treatment for coronavirus disease 2019 (COVID-19) is disclosed herein. The method comprises administering a therapeutically effective dose of a combination of ribavirin and minocycline. A pharmaceutical composition comprising ribavirin and minocycline is also disclosed herein. The pharmaceutical composition may further include one or more pharmaceutical excipients.

    Solution, Lotion, Gel, and Cream for Use to Prevent Razor Bumps

    公开(公告)号:US20230000892A1

    公开(公告)日:2023-01-05

    申请号:US17364790

    申请日:2021-06-30

    申请人: Kenneth Okafor

    发明人: Kenneth Okafor

    IPC分类号: A61K31/7056 A61K9/06

    摘要: An article of manufacture for providing a solution, lotion, gel, and cream for use as an aftershave to prevent razor bumps is disclosed. A solution, lotion, gel, and cream having a concentration of clindamycin phosphate between 0.5% and 1.0% may be applied immediately after shaving to a user's skin to prevent razor bumps on various parts of the body that are typically shaved. The present invention may be applied as a skin treatment to the face and neck, underarms, legs, and pubic areas.

    Novel Immunodulating Small Molecules

    公开(公告)号:US20230000887A1

    公开(公告)日:2023-01-05

    申请号:US17824362

    申请日:2022-05-25

    摘要: The present invention includes novel compositions and methods for treating comprising a compound with the Formula I: wherein n=0, 1, 2, 3, 4, or 5; X=NH or O or S; Y=phenyl, or a phenyl group substituted with at least one methyl, a phenyl group substituted with at least one nitro, a phenyl group substituted with at least one nitrogen, a phenyl group substituted with at least one boron, aryl, substituted aryl, heteroaryl, four to six membered cycloalkyl, four to six membered heterocycloalkyl; R=H, C(O)R2, SO2R2; R1=H, C(O)R2, SO2R2; R2=Ethyl, methyl, isopropyl, n-propyl, t-butyl, n-butyl, NH2, NR3R4; R3, R4=Ethyl, methyl, isopropyl, n-propyl, t-butyl, n-butyl, three to six membered cycloalkyl, and Z=NH, or O, or none, and optionally wherein both X and Z are not both S, and wherein the amount of the compound is selected to either inhibit or activate the immune response.